"Secondary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prevention of recurrences or exacerbations of a disease or complications of its therapy.
Descriptor ID |
D055502
|
MeSH Number(s) |
E02.897 N02.421.726.825 N06.850.780.750
|
Concept/Terms |
Secondary Prevention- Secondary Prevention
- Prevention, Secondary
- Preventions, Secondary
- Secondary Preventions
- Secondary Disease Prevention
- Disease Prevention, Secondary
- Disease Preventions, Secondary
- Prevention, Secondary Disease
- Preventions, Secondary Disease
- Secondary Disease Preventions
Relapse Prevention- Relapse Prevention
- Prevention, Relapse
- Preventions, Relapse
- Relapse Preventions
Early Therapy- Early Therapy
- Early Therapies
- Therapies, Early
- Therapy, Early
|
Below are MeSH descriptors whose meaning is more general than "Secondary Prevention".
Below are MeSH descriptors whose meaning is more specific than "Secondary Prevention".
This graph shows the total number of publications written about "Secondary Prevention" by people in this website by year, and whether "Secondary Prevention" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2000 | 0 | 4 | 4 |
2001 | 0 | 2 | 2 |
2002 | 0 | 7 | 7 |
2003 | 0 | 7 | 7 |
2004 | 0 | 3 | 3 |
2005 | 1 | 5 | 6 |
2006 | 0 | 7 | 7 |
2007 | 0 | 5 | 5 |
2008 | 1 | 6 | 7 |
2009 | 1 | 7 | 8 |
2010 | 0 | 7 | 7 |
2011 | 3 | 10 | 13 |
2012 | 2 | 4 | 6 |
2013 | 2 | 9 | 11 |
2014 | 1 | 5 | 6 |
2015 | 1 | 0 | 1 |
2016 | 4 | 3 | 7 |
2017 | 1 | 2 | 3 |
2018 | 3 | 2 | 5 |
2019 | 3 | 4 | 7 |
2020 | 2 | 1 | 3 |
2021 | 4 | 2 | 6 |
2022 | 0 | 3 | 3 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Secondary Prevention" by people in Profiles.
-
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE. Am Heart J. 2023 Oct; 264:31-39.
-
Highlights in ASCVD Primary Prevention forĀ 2021. J Am Heart Assoc. 2022 07 05; 11(13):e025973.
-
Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends. Osteoporos Int. 2022 Aug; 33(8):1659-1676.
-
Advances in Stroke: Treatments-Preventive. Stroke. 2022 02; 53(2):608-610.
-
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 01; 7(1):69-95.
-
Risk Factors Control and Early Recurrent Cerebral Infarction in Patients with Symptomatic Intracranial Atherosclerotic Disease. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105914.
-
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.
-
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease. United European Gastroenterol J. 2021 06; 9(5):552-560.
-
LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial. Atherosclerosis. 2021 03; 320:1-9.
-
Management of Patients With a Patent Foramen Ovale With History of Stroke or TIA. JAMA. 2021 Jan 05; 325(1):81-82.